Mixed Topics
From the Journals
Cancer Cases, Deaths in Men Predicted to Surge by 2050
Researchers analyzed data from the 2022 Global Cancer Observatory (GLOBOCAN), which provides national-level estimates for cancer cases and deaths...
Commentary
Cancer Treatment 101: A Primer for Non-Oncologists
Doctor explains why he thinks time of diagnosis is the best time for molecular testing of a new malignant tumor.
Feature
When Childhood Cancer Survivors Face Sexual Challenges
The disruptions caused by cancer and its treatment can interfere with normal physiological and psychological development, leading to issues with...
Latest News
Diagnosing, Treating Rashes In Patients on Immune Checkpoint Inhibitors
Cutaneous immune-related adverse events are the most frequently reported and most visible adverse effects of checkpoint inhibition.
Feature
Jeffrey Weber, MD, PhD, Giant of Cancer Care, Dies
He was a principal investigator on many studies, including pivotal clinical drug trials in melanoma.
Latest News
Study Identifies Oral Antibiotics Linked to Severe Cutaneous Reactions
The results “underscore the importance of judicious prescribing, with preferential use of antibiotics associated with a lower risk when clinically...
Feature
Immunotherapy May Be Overused in Dying Patients With Cancer
“There are patients who are getting immunotherapy who shouldn’t,” according to a surgical oncologist from Yale.
From the Journals
Can Addressing Depression Reduce Chemo Toxicity in Older Adults?
Researchers evaluated whether greater reductions in grade 3 chemotherapy-related toxicities occurred with geriatric assessment-driven...
From the Journals
Tool Can Help Predict Futile Surgery in Pancreatic Cancer
Researchers evaluate patients with anatomically resectable pancreatic ductal adenocarcinoma who underwent pancreatic resection.
From the Journals
The Last 30 Days: How Oncologists’ Choices Affect End-of-Life Cancer Care
Researchers analyze data from more than 17,000 patients who died of cancer between 2012 and 2017.
From the Journals
Ancient Viruses in Our DNA Hold Clues to Cancer Treatment
Targeting remnants of a virus in our DNA could lead to more effective cancer treatment with fewer side effects.